Principal Financial Group Inc. Lowers Stake in Amedisys, Inc. (NASDAQ:AMED)

Principal Financial Group Inc. cut its stake in Amedisys, Inc. (NASDAQ:AMED) by 30.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 75,526 shares of the health services provider’s stock after selling 33,149 shares during the quarter. Principal Financial Group Inc.’s holdings in Amedisys were worth $7,289,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Signaturefd LLC raised its holdings in Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after purchasing an additional 530 shares in the last quarter. Commonwealth Equity Services LLC lifted its position in Amedisys by 10.9% during the second quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock valued at $381,000 after acquiring an additional 409 shares during the last quarter. Versor Investments LP lifted its position in Amedisys by 23.5% during the second quarter. Versor Investments LP now owns 6,721 shares of the health services provider’s stock valued at $617,000 after acquiring an additional 1,279 shares during the last quarter. Privium Fund Management UK Ltd acquired a new stake in Amedisys in the second quarter valued at approximately $1,284,000. Finally, Arizona State Retirement System grew its holdings in Amedisys by 2.0% in the second quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after purchasing an additional 177 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Shares of AMED stock opened at $90.79 on Wednesday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.97 billion, a PE ratio of 36.03, a PEG ratio of 1.84 and a beta of 0.73. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The business’s fifty day simple moving average is $90.31 and its 200-day simple moving average is $94.46.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $587.67 million during the quarter, compared to analysts’ expectations of $586.75 million. During the same quarter last year, the business posted $0.98 earnings per share. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. Analysts expect that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.